Emergex and Brazil's IBMP Announce Clinical Development Coll

Emergex and Brazil’s IBMP to co-fund Phase II and Phase III studies of Emergex’s Dengue Fever and Betacoronavirus T cell-priming immune set-point therapeutic

Related Keywords

Switzerland , United States , Pennsylvania , Brazil , Fiocruz , Estado Do Rio , United Kingdom , America , Brazilian , Storme Moore Thornicroft , Pedro Ribeiro Barbosa , Thomas Rademacher , Rachelle Babb , Steering Committee , Linkedin , Twitter , Ministry Of Health , Molecular Biology Institute Of Paran , Emergex Vaccines Holding Limited , Industrial Complex Of Health Complexo Econ , Dengue Fever , Vaccines Holding Limited , Molecular Biology Institute , Joint Steering Committee , Universal Influenza , Ribeiro Barbosa , Emergex Dengue , Industrial Complex , Complexo Econ , Emergex , Hand , Brazil S , Ibmp , Announce , Clinical , Development , Collaboration , For , It , Cell Priming , Immune , Set Point , Candidates ,